Does Medicare Cover GLP-1 Medications in 2026?
INS-000001
Direct Answer
Yes, with an important distinction. Medicare Part D has long covered Ozempic, Mounjaro, Rybelsus, Trulicity, and Victoza for type 2 diabetes, and Wegovy for cardiovascular risk reduction, when a plan's formulary includes them. What's new: starting July 1, 2026, the Medicare GLP-1 Bridge, a demonstration program, covers Wegovy, the Zepbound KwikPen, and Foundayo specifically for weight loss at a flat $50 monthly copay. This is the first time Medicare has covered a GLP-1 medication for weight loss alone, something federal law had excluded since Part D began in 2006.
Ozempic and Mounjaro Are Not Part of the Bridge Program
This is a common point of confusion. Ozempic and Mounjaro remain covered separately, through standard Part D, for their diabetes indication. They are not included in the Bridge program itself, since that program specifically targets the weight-management-approved products.
Who Qualifies for the Bridge Program
According to Medicare.gov, you generally qualify if you have a BMI of 35 or higher, or a BMI between 30 and 34.99 with at least one qualifying condition, including heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease. You must be enrolled in a Medicare Part D or Medicare Advantage plan with drug coverage, and not every plan participates, so confirming your specific plan is enrolled matters.
Important Details About the $50 Copay
The $50 flat copay does not count toward your Part D deductible or annual out-of-pocket costs, and it applies even if you receive Extra Help, the low-income subsidy, since Extra Help's cost-sharing reductions don't apply to Bridge program drugs specifically. Your prior authorization, once approved, stays valid through refills and dose changes until December 31, 2027, unless you switch to a different GLP-1 medication.
What Happens After the Bridge Program Ends
The Bridge program runs through December 31, 2027, and is intended to lead into a separate model called BALANCE, expected to begin in January 2027. Coverage beyond 2027 is not guaranteed under current program design, worth watching as the date approaches.
How to Get Started
Talk to your provider about whether you meet the eligibility criteria. Your provider submits the prescription and, when required, completes the prior authorization directly with your plan. You'll receive written confirmation once your GLP-1 drug is approved under the Bridge program.
References
- Medicare.gov: Weight Loss Drugs
- eHealth: What to Know About the GLP-1 Medicare Bridge Program
- Middle Way Nutrition: Medicare GLP-1 Coverage 2026
Related Resources
- Your Complete Guide to the Medicare GLP-1 Bridge Program
- Does Medicaid Cover GLP-1 Medications?
Related Articles
Explore More
Explore the full GLP-1 Tracker knowledge base on DietApp.com
Get Started
Download DietApp.com to track your medication and progress, whatever your coverage situation.
About DietApp.com
DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This page is for general informational purposes and is not insurance, legal, or medical advice. Coverage rules change frequently, always confirm current details directly with Medicare, your specific plan, or your provider.
medicare-glp-1-coverage